InvestorsHub Logo
Followers 19
Posts 334
Boards Moderated 0
Alias Born 07/25/2016

Re: Titan V post# 39373

Wednesday, 06/07/2017 9:46:16 PM

Wednesday, June 07, 2017 9:46:16 PM

Post# of 48316
A 5% complete response rate in advanced melanoma all comers according to the Epac combination data... not impressive. A 63% BORR sounds good, but when you realize that these patients are mostly just partial responders, then you know that they will be seeking a better solution.

Incyte's Epac is an improvement, but it really doesn't get the job done. T-vec is even worse.